ArticleJournal of orthopaedic surgery and research2025
Dose-response relationship between symptom duration and postoperative patient-reported outcomes in patients with adult spinal deformity.
Article in Journal of orthopaedic surgery and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectiveTo ascertain whether preoperative symptom duration elevated the risk of adverse patient-reported outcomes (PROs) and to further delve into whether the existence of a dose-response relationship in patients with adult spinal deformity (ASD).
methodsThe retrospective cohort comprised consecutive patients who underwent spinal corrective surgery from January 2018 to May 2022. Demographic, radiological and surgical factors were included from the electronic medical records. To identify the impact of mismatched variables, we performed conditional logistic regression after adjusting for potential confounding factors. Further, nonlinear relationship between symptom duration and postoperative unfavorable PROs at 24-month follow-up was conducted based on restricted cubic splines (RCS) analysis, with the adjustments for possible confounders. If a nonlinear relationship was identified, a two-piecewise regression model would be employed to ascertain the threshold effect. Finally, the result of receiver operating characteristic (ROC) curve was employed to further corroborated the rationality of RCS results.
resultsWe matched 122 controls to 61 unfavorable PROs patients. In the fully adjusted linear model, for every additional month of symptom duration, the risk of unfavorable patient-reported outcomes (u-PROs) increased by 79%, with an odds ratio of 1.79 (95% CI: 1.25-2.04, p < 0.001). Patients with 6-18 months of symptom duration had comparable risk of u-PRO, whereas patients with more than 24 months had an increasingly higher risk of u-PRO (OR = 4.74, 95% CI 3.11 - 7.93, p < 0.001). Based on the results of the restricted cubic spline (RCS) analysis with three knots, a significant nonlinear relationship was observed. Notably, we found a substantial increase in the risk of u-PROs when the duration of symptoms exceeded 18.4 months. Additionally, ROC curve with an optimal cut-off of 18.5 months was identified, which verified the reliability of RCS analysis.
conclusionsWe determine that 18.4 months was a threshold of preoperative symptom duration that shifted the risk of unfavorable PROs after spinal corrective surgery, and there was a dose-response relationship.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.